PROTEOSTASIS THERAPEUTICS, INC. Business Finance Contracts & Agreements

45 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Amendment No. 6 to Securities Purchase Agreement, dated October 13, 2023
Purchase Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2023
Form of Securities Purchase Agreement, dated as of October 3, 2023
Purchase Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
NY
2023
Form of Wainwright Warrant
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2023
Form of Common Warrant
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2023
Form of Pre-Funded Warrant
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2023
Form of Amendment No. 5 to Securities Purchase Agreement, dated July 21, 2023
Purchase Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2023
Form of Amendment No. 4 to Securities Purchase Agreement, dated May 1, 2023
Purchase Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2023
Form of Securities Purchase Agreement, dated as of April 20, 2023
Purchase Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
NY
2023
Form of Wainwright Warrant
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2023
Form of Common Warrant
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2023
Form of Pre-Funded Warrant
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2023
Form of Amendment No. 2 to the Registration Rights Agreement, dated December 5, 2022
Registration Rights Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2022
Form of Warrant, dated December 5, 2022
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2022
Form of Amendment No. 2 to the Securities Purchase Agreement dated December 5, 2022
Purchase Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2022
Form of Registration Rights Agreement Amendment, dated October 24, 2022
Registration Rights Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2022
Form of Warrant, dated October 24, 2022
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2022
Form of Securities Purchase Agreement Amendment, dated October 24, 2022
Purchase Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2022
Kineta, Inc. Amended and Restated 2008 Stock Plan (the Kineta 2008 Plan) and associated forms
Stock Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
WA
2022
Form of Registration Rights Agreement, dated June 5, 2022, by each of the parties named therein
Registration Rights Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2022
Form of Securities Purchase Agreement, dated June 5, 2022, by each of the parties named therein
Purchase Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2022
Asset Purchase Agreement, dated June 5, 2022, by and among Yumanity and Janssen
Purchase Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2022
Sixth Amendment and Consent to Loan and Security Agreement dated as of April 13, 2021, by and among Yumanity, Inc., the lenders party thereto and Hercules Capital, Inc
Loan Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
CA
2021
Fifth Amendment and Consent to Loan and Security Agreement dated as of March 29, 2021, by and among Yumanity, Inc., the lenders party thereto and Hercules Capital, Inc
Loan Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
CA
2021
Amended and Restated Warrant Agreement to Purchase Common Stock of the Company issued to Hercules Capital, Inc., dated December 22, 2020
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
CA
2021
Yumanity Therapeutics, Inc. Amended and Restated 2018 Stock Option and Grant Plan and forms of award agreements thereunder
Stock Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2020
Registration Rights Agreement, dated as of December 22, 2020 by among the Company (formerly known as Proteostasis Therapeutics, Inc.) and certain purchasers listed therein
Registration Rights Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
NY
2020
Fourth Amendment and Consent to Loan and Security Agreement dated as of December 22, 2020, by and among Yumanity, Inc. (formerly Yumanity Therapeutics, Inc.), the lenders party...
Loan Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
CA
2020
Unconditional Secured Guaranty and Pledge Agreement, dated December 22, 2020 by and between the Company (formerly known as Proteostasis Therapeutics, Inc.) and Hercules Capital,...
Guaranty Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
CA
2020
Form of Registration Rights Agreement
Registration Rights Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
NY
2020
Subscription Agreement, dated as of December 14, 2020 by and among Proteostasis Therapeutics, Inc. and the Purchasers named therein
Subscription Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
NY
2020
Warrant to Purchase Limited Liability Company Interests issued to Oxford Finance LLC dated June 14, 2018
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
NY
2020
Warrant to Purchase Limited Liability Company Interests issued to Silicon Valley Bank on June 14, 2018
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
NY
2020
Common Unit Warrant issued to N. Anthony Coles on August 14, 2015
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2020
Common Unit Warrant issued to Redmile Biotechnologies Investments I AF, LP (as predecessor to Redmile Biopharma Investments I, L.P.) on August 14, 2015
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2020
Common Unit Warrant issued to Redmile Capital Offshore II Master Fund, Ltd. on August 14, 2015
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2020
Common Unit Warrant issued to Alexandria Equities, LLC (as predecessor to Alexandria Venture Investments, LLC) on October 9, 2015
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2020
U.S. Small Business Administration Paycheck Protection Program Note with Silicon Valley Bank, dated as of April 24, 2020
Note Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2020
Warrant Agreement to Purchase Preferred Units of Yumanity Holdings, LLC issued to Hercules Capital, Inc., dated December 20, 2019
Warrant Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
CA
2020
Loan and Security Agreement, by and among Yumanity Therapeutics, Inc. and Hercules Capital, Inc., dated as December 20, 2019
Loan Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
CA
2020
Assignment and Release Agreement between the Company and Cystic Fibrosis Foundation, dated December 19, 2018
Release Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2019